Camille L Bedrosian
CIK 1326969 · Chief Medical Officer · last filed 2026-03-09
Camille L Bedrosian is a Chief Medical Officer who has filed 44 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for AMLX, was dated Mar 9, 2026. Across all open-market trades the lifetime net is −$6.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.28M
5
44
-$6.51M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMLX | Chief Medical Officer | 265,285 | $14.59 | $3.87M | -$473.8K | 10 | 2026-03-09 |
| RYTM | Director | 7,000 | $88.38 | $618.7K | $0 | 8 | 2025-06-26 |
| CRNX | Director | 16,300 | $34.47 | $561.9K | $0 | 6 | 2025-06-13 |
| RARE | EVP and Chief Medical Officer | 50,601 | $24.35 | $1.23M | -$6.04M | 19 | 2023-03-03 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | VP, Chief Medical Officer | — | — | — | $0 | 1 | 2007-04-18 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-09 | AMLX | Grant (A) | +95,990 | $0 | EDGAR |
| 2026-03-04 | AMLX | Sell (S) | −6,461 | -$94.2K | EDGAR |
| 2025-12-03 | AMLX | Sell (S) | −6,580 | -$94.4K | EDGAR |
| 2025-10-02 | AMLX | Sell (S) | −12,039 | -$175.5K | EDGAR |
| 2025-06-26 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | RYTM | Exer (M) | +4,000 | $0 | EDGAR |
| 2025-06-13 | CRNX | Grant (A) | +6,900 | $0 | EDGAR |
| 2025-04-02 | AMLX | Sell (S) | −12,425 | -$43.1K | EDGAR |
| 2025-03-10 | AMLX | Grant (A) | +68,420 | $0 | EDGAR |
| 2024-12-03 | AMLX | Sell (S) | −5,421 | -$30.0K | EDGAR |